US Stock MarketDetailed Quotes

LEGN Legend Biotech

Watchlist
  • 38.050
  • +0.110+0.29%
Trading Mar 18 13:11 ET
6.99BMarket Cap-39.64P/E (TTM)

Legend Biotech Key Stats

Legend Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 241.319M--
--2025/Q1-- / 191.943M--
--2024/Q4186.522M / 178.998M--
Nov 12, 20242024/Q3160.205M / 146.084M--
Aug 9, 20242024/Q2186.523M / 126.107M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 241.319M--
--2025/Q1-- / 191.943M--
--2024/Q4186.522M / 178.998M--
Nov 12, 20242024/Q3160.205M / 146.084M--
Aug 9, 20242024/Q2186.523M / 126.107M--

Unlock Free Earnings Estimates

Legend Biotech Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 17, 2025

Strong Buy

  • Buy

    93.33%
  • Hold

    6.67%
  • Sell

    0.00%

Price Target

No Data